Core Viewpoint - A class action lawsuit has been filed against C3.ai, alleging that the company and its executives misled investors regarding its financial health and growth prospects, violating the Securities Exchange Act of 1934 [1][2]. Company Summary - The lawsuit claims that C3.ai projected an overly optimistic view of its revenue and growth potential, while downplaying risks associated with CEO Thomas M. Siebel's health issues [2]. - The case highlights a significant drop in C3.ai's stock price, which fell by more than 25% following the company's disappointing financial announcement on August 8, 2025, where it disclosed preliminary first-quarter results that did not meet expectations and lowered its revenue guidance for the fiscal year [3]. - The lawsuit seeks to represent investors who purchased C3.ai securities during the class period from February 26, 2025, to August 8, 2025, and those interested in serving as lead plaintiffs must file a motion by October 21, 2025 [4]. Industry Context - The investigation focuses on whether C3.ai's public statements were misleading, particularly regarding the impact of CEO Siebel's health on the company's ability to achieve financial targets [5]. - Hagens Berman, the law firm leading the investigation, emphasizes the importance of corporate accountability and has a history of securing significant recoveries for investors harmed by corporate negligence [6].